Filing Details

Accession Number:
0001140361-12-018135
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-29 17:56:40
Reporting Period:
2012-03-27
Filing Date:
2012-03-29
Accepted Time:
2012-03-29 16:56:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
69499 Mylan Inc. MYL Pharmaceutical Preparations (2834) 251211621
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1388111 Rajiv Malik 1500 Corporate Drive
Canonsburg PA 15317
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-03-27 5,660 $0.00 160,546 No 4 M Direct
Common Stock Disposition 2012-03-28 1,833 $23.15 158,713 No 4 S Direct
Common Stock Acquisiton 2012-03-27 39,623 $0.00 198,336 No 4 M Direct
Common Stock Disposition 2012-03-28 13,081 $23.15 185,255 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2012-03-27 5,660 $0.00 5,660 $0.00
Common Stock Restricted Stock Units Acquisiton 2012-03-27 39,623 $0.00 39,623 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
0 No 4 M Direct
Footnotes
  1. On February 24, 2012, a duplicate copy of a Form 4 for the reporting person originally submitted on July 29, 2009, was inadvertently re-filed and should be ignored.
  2. Represents shares sold to cover the tax liability associated with the vesting of a portion of the RSUs granted on March 27, 2009. These shares were sold pursuant to a 10b5-1 trading plan dated March 8, 2012.
  3. Represents the weighted price of the reporting person's disposition, pursuant to the trading plan described above, of 14,914 shares in transactions ranging from $23.10 to $23.31.
  4. Represents shares sold to cover the tax liability associated with the vesting of the performance RSUs granted on March 27, 2009. These shares were sold pursuant to a 10b5-1 trading plan dated March 8, 2012.
  5. Each RSU represents the right to receive one share of Mylan Inc. common stock. Each of these awards vested fully on March 27, 2012.